View in EDS HTML Full Text PDF Full Text

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.

Saved in:
Bibliographic Details
Title: A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
Authors: Lynce, Filipa1,2 (AUTHOR), Wang, Hongkun3 (AUTHOR), Petricoin, Emanuel F.4 (AUTHOR), Pohlmann, Paula R.1,2 (AUTHOR), Smaglo, Brandon5 (AUTHOR), Hwang, Jimmy6 (AUTHOR), He, Aiwu R.1,2 (AUTHOR), Subramaniam, Deepa S.1,2,7 (AUTHOR), Deeken, John8 (AUTHOR), Marshall, John1,2 (AUTHOR), Pishvaian, Michael J.1,2 (AUTHOR) pishvaim@georgetown.edu
Source: Cancer Chemotherapy & Pharmacology. Nov2019, Vol. 84 Issue 5, p1145-1151. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 139163614
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lynce%2C+Filipa%22">Lynce, Filipa</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Hongkun%22">Wang, Hongkun</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Petricoin%2C+Emanuel+F%2E%22">Petricoin, Emanuel F.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pohlmann%2C+Paula+R%2E%22">Pohlmann, Paula R.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Smaglo%2C+Brandon%22">Smaglo, Brandon</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hwang%2C+Jimmy%22">Hwang, Jimmy</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Aiwu+R%2E%22">He, Aiwu R.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Subramaniam%2C+Deepa+S%2E%22">Subramaniam, Deepa S.</searchLink><relatesTo>1,2,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deeken%2C+John%22">Deeken, John</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marshall%2C+John%22">Marshall, John</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pishvaian%2C+Michael+J%2E%22">Pishvaian, Michael J.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> pishvaim@georgetown.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Chemotherapy+%26+Pharmacology%22">Cancer Chemotherapy & Pharmacology</searchLink>. Nov2019, Vol. 84 Issue 5, p1145-1151. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=139163614
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-019-03947-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1145
    Titles:
      – TitleFull: A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lynce, Filipa
      – PersonEntity:
          Name:
            NameFull: Wang, Hongkun
      – PersonEntity:
          Name:
            NameFull: Petricoin, Emanuel F.
      – PersonEntity:
          Name:
            NameFull: Pohlmann, Paula R.
      – PersonEntity:
          Name:
            NameFull: Smaglo, Brandon
      – PersonEntity:
          Name:
            NameFull: Hwang, Jimmy
      – PersonEntity:
          Name:
            NameFull: He, Aiwu R.
      – PersonEntity:
          Name:
            NameFull: Subramaniam, Deepa S.
      – PersonEntity:
          Name:
            NameFull: Deeken, John
      – PersonEntity:
          Name:
            NameFull: Marshall, John
      – PersonEntity:
          Name:
            NameFull: Pishvaian, Michael J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 03445704
          Numbering:
            – Type: volume
              Value: 84
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer Chemotherapy & Pharmacology
              Type: main
ResultId 1